Cargando…
Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model
Breast cancer is the most common malignancy in women of the Western world. Doxorubicin (DOX) continues to be used extensively to treat early-stage or node-positive breast cancer, human epidermal growth factor receptor-2 (HER2)-positive breast cancer, and metastatic disease. We have previously demons...
Autores principales: | Bose, Chhanda, Awasthi, Sanjay, Sharma, Rajendra, Beneš, Helen, Hauer-Jensen, Martin, Boerma, Marjan, Singh, Sharda P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843244/ https://www.ncbi.nlm.nih.gov/pubmed/29518137 http://dx.doi.org/10.1371/journal.pone.0193918 |
Ejemplares similares
-
Multi-Omic Analysis Reveals Different Effects of Sulforaphane on the Microbiome and Metabolome in Old Compared to Young Mice
por: Jun, Se-Ran, et al.
Publicado: (2020) -
Sulforaphane prevents age‐associated cardiac and muscular dysfunction through Nrf2 signaling
por: Bose, Chhanda, et al.
Publicado: (2020) -
Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells
por: Bose, Chhanda, et al.
Publicado: (2021) -
Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
por: Calcabrini, Cinzia, et al.
Publicado: (2020) -
Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action
por: Pharoah, Blaze M., et al.
Publicado: (2023)